SEARCH

SEARCH BY CITATION

References

  • Chang, D.W., Xing, Z., Pan, Y., Algeciras-Schimnich, A., Barnhart, B.C., Yaish-Ohad, S., Peter, M.E. & Yang, X. (2002) c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO Journal, 21, 37043714.
  • Davies, S.P., Reddy, H., Caivano, M. & Cohen, P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochemical Journal, 351, 95105.
  • Freemerman, A.J., Turner, A.J., Birrer, M.J., Szabo, E., Valerie, K. & Grant, S. (1996) Role of c-jun in human myeloid leukemia cell apoptosis induced by pharmacological inhibitors of protein kinase C. Molecular Pharmacology, 49, 788795.
  • Fukazawa, T., Fujiwara, T., Uno, F., Teraishi, F., Kadowaki, Y., Itoshima, T., Takata, Y., Kagawa, S., Roth, J.A., Tschopp, J. & Tanaka, N. (2001) Accelerated degradation of cellular FLIP protein through the ubiquitin–proteasome pathway in p53-mediated apoptosis of human cancer cells. Oncogene, 20, 52255231.
  • Gomez-Angelats, M. & Cidlowski, J.A. (2001) Protein kinase C regulates FADD recruitment and death-inducing signaling complex formation in Fas/CD95-induced apoptosis. Journal of Biological Chemistry, 276, 4494444952.
  • Grundhoff, A.T., Kremmer, E., Türeci, Ö., Glieden, A., Gindorf, C., Atz, J., Mueller-Lantzsch, N., Schubach, W.H. & Grässer, F.A. (1999) Characterization of DP103, a novel DEAD box protein that binds to the Epstein–Barr virus nuclear proteins EBNA2 and EBNA3C. Journal of Biological Chemistry, 274, 1913619144.
  • Guo, B.C. & Xu, Y.H. (2001) Bcl-2 over-expression and activation of protein kinase C suppress the trail-induced apoptosis in Jurkat T cells. Cell Research, 11, 101106.
  • Herbert, J.M., Augereau, J.M., Gleye, J. & Maffrand, J.P. (1990) Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochemical and Biophysical Research Communications, 172, 993999.
  • Holmstrom, T.H., Chow, S.C., Elo, I., Coffey, E.T., Orrenius, S., Sistonen, L. & Eriksson, J.E. (1998) Suppression of Fas/APO-1-mediated apoptosis by mitogen-activated kinase signaling. Journal of Immunology, 160, 26262636.
  • Holmstrom, T.H., Tran, S.E., Johnson, V.L., Ahn, N.G., Chow, S.C. & Eriksson, J.E. (1999) Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis. Molecular and Cellular Biology, 19, 59916002.
  • Holmstrom, T.H., Schmitz, I., Soderstrom, T.S., Poukkula, M., Johnson, V.L., Chow, S.C., Krammer, P.H. & Eriksson, J.E. (2000) MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. EMBO Journal, 19, 54185428.
  • Humbert, O., Hermine, T., Hernandez, H., Bouget, T., Selves, J., Laurent, G., Salles, B. & Lautier, D. (2002) Implication of protein kinase C in the regulation of DNA mismatch repair protein expression and function. Journal of Biological Chemistry, 277, 1806118068.
  • Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.L., Schroter, M., Burns, K., Mattmann, C., Rimoldi, D., French, L.E. & Tschopp, J. (1997) Inhibition of death receptor signals by cellular FLIP. Nature, 388, 190195.
  • Jarvis, W.D., Turner, A.J., Povirk, L.F., Traylor, R.S. & Grant, S. (1994) Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Research, 54, 17071714.
  • Kim, H., Whartenby, K.A., Georgantas, R.W., Wingard, J. & Civin, C.I. (2002) Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis. Stem Cells, 20, 174182.
  • Kim, Y., Suh, N., Sporn, M. & Reed, J.C. (2002) An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis. Journal of Biological Chemistry, 277, 2232022329.
  • Krueger, A., Baumann, S., Krammer, P.H. & Kirchhoff, S. (2001) FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Molecular and Cellular Biology, 21, 82478254.
  • Lee, S.K., Qing, W.G., Mar, W., Luyengi, L., Mehta, R.G., Kawanishi, K., Fong, H.H., Beecher, C.W., Kinghorn, A.D. & Pezzuto, J.M. (1998) Angoline and chelerythrine, benzophenanthridine alkaloids that do not inhibit protein kinase C. Journal of Biological Chemistry, 273, 1982919833.
  • Li, D., Sweeney, G., Wang, Q. & Klip, A. (1999) Participation of PI3K and atypical PKC in Na+–K+–pump stimulation by IGF-I in VSMC. American Journal of Physiology, 276, H2109H2116.
  • Martiny-Baron, G., Kazanietz, M.G., Mischak, H., Blumberg, P.M., Kochs, G., Hug, H., Marme, D. & Schachtele, C. (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. Journal of Biological Chemistry, 268, 91949197.
  • Mitsiades, N., Mitsiades, C.S., Poulaki, V., Anderson, K.C. & Treon, S.P. (2002) Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells. Blood, 99, 21622171.
  • Newton, A.C. (2002) Analyzing protein kinase C activation. Methods in Enzymology, 345, 499506.
  • Ohtsuka, T. & Zhou, T. (2002) Bisindolylmaleimide VIII enhances DR5-mediated apoptosis through the MKK4/JNK/p38 kinase and the mitochondrial pathways. Journal of Biological Chemistry, 271, 2929429303.
  • Pitti, R.M., Marsters, S.A., Ruppert, S., Donahue, C.J., Moore, A. & Ashkenazi, A. (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. Journal of Biological Chemistry, 271, 1268712690.
  • Ruiz-Ruiz, C., Robledo, G., Font, J., Izquierdo, M. & Lopez-Rivas, A. (1999) Protein kinase C inhibits CD95 (Fas/APO-1)-mediated apoptosis by at least two different mechanisms in Jurkat T cells. Journal of Immunology, 163, 47374746.
  • Sarker, M., Ruiz-Ruiz, C. & Lopez-Rivas, A. (2001) Activation of protein kinase C inhibits TRAIL-induced caspases activation, mitochondrial events and apoptosis in a human leukemic T cell line. Cell Death and Differentiation, 8, 172181.
  • Schneider, P. & Tschopp, J. (2000) Apoptosis induced by death receptors. Pharmaceutica Acta Helvetiae, 74, 281286.
  • Sheridan, J.P., Marsters, S.A., Pitti, R.M., Gurney, A., Skubatch, M., Baldwin, D., Ramakrishnan, L., Gray, C.L., Baker, K., Wood, W.I., Goddard, A.D., Godowski, P. & Ashkenazi, A. (1997) Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science, 277, 818821.
  • Shinohara, H., Kayagaki, N., Yagita, H., Oyaizu, N., Ohba, M., Kuroki, T. & Ikawa, Y. (2001) A protective role of PKCepsilon against TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in glioma cells. Biochemical and Biophysical Research Communications, 284, 11621167.
  • Sweeney, J.F., Nguyen, P.K., Atkins, K.B. & Hinshaw, D.B. (2000) Chelerythrine chloride induces rapid polymorphonuclear leukocyte apoptosis through activation of caspase-3. Shock, 13, 464471.
  • De Thonel, A., Bettaieb, A., Jean, C., Laurent, G. & Quillet-Mary, A. (2001) Role of protein kinase C zeta isoform in Fas resistance of immature myeloid KG1a leukaemic cells. Blood, 98, 37703777.
  • Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E. & Loriolle, F. (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. Journal of Biological Chemistry, 266, 1577115781.
  • Trauzold, A., Wermann, H., Arlt, A., Schutze, S., Schafer, H., Oestern, S., Roder, C., Ungefroren, H., Lampe, E., Heinrich, M., Walczak, H. & Kalthoff, H. (2001) CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells. Oncogene, 20, 42584269.
  • Varadhachary, A.S., Peter, M.E., Perdow, S.N., Krammer, P.H. & Salgame, P. (1999) Selective up-regulation of phosphatidylinositol 3′-kinase activity in Th2 cells inhibits caspase-8 cleavage at the death-inducing complex: a mechanism for Th2 resistance from Fas-mediated apoptosis. Journal of Immunology, 163, 47724779.
  • Villalba, M., Bushway, P. & Altman, A. (2001) Protein kinase C-theta mediates a selective T cell survival signal via phosphorylation of BAD. Journal of Immunology, 166, 59555963.
  • Wen, J., Ramadevi, N., Nguyen, D., Perkins, C., Worthington, E. & Bhalla, K. (2000) Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells. Blood, 96, 39003906.
  • Wiley, S.R., Schooley, K., Smolak, P.J., Din, W.S., Huang, C.P., Nicholl, J.K., Sutherland, G.R., Smith, T.D., Rauch, C. & Smith, C.A. (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 3, 673682.
  • Willems, F., Amraoui, Z., Vanderheyde, N., Verhasselt, V., Aksoy, E., Scaffidi, C., Peter, M.E., Krammer, P.H. & Goldman, M. (2000) Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide. Blood, 95, 34783482.
  • Yamamoto, S., Seta, K., Morisco, C., Vatner, S.F. & Sadoshima, J. (2001) Chelerythrine rapidly induces apoptosis through generation of reactive oxygen species in cardiac myocytes. Journal of Molecular and Cellular Cardiology, 33, 18291848.
  • Zang, D.Y., Goodwin, R.G., Loken, M.R., Bryant, E. & Deeg, H.J. (2001) Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro haemopoiesis. Blood, 98, 30583065.